Relationship between medication adherence for opioid use disorder and health care costs and health care events in a claims dataset
Medication for opioid use disorder (MOUD) has well-documented benefits for treating OUD, though its efficacy depends on patient adherence. We know little about outcomes of MOUD nonadherence compared to treatment regimens without MOUD, and this article aims to address the gap. This analysis focused on office-based MOUD treatment (buprenorphine and naltrexone) to evaluate the long-term impact of adherence on subsequent health care costs and health care events.
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: Shirley Liao, Steve Jang, Jordan A. Tharp, Natalie A. Lester Source Type: research
More News: Addiction | Health Management | Jordan Health | Middle East Health | Substance Abuse | Substance Abuse Disorders